Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

Emig M., Saußele S., Wittor H., Weißer A., Reiter A., Willer A., Berger U., Hehlmann R., Cross N.C.P., Hochhaus A.

Leukemia (1999) 13, 1825-1832

Detection and quantification of bcr/abl transcripts using a novel real-time approach with specific fluorescent Hybridization Probes

Wittor H., Emig M., Betzl G., Helmann R., Leying H., Hochhaus A.

Roche 199-2115506

Evaluation of the Roche Diagnostics LightCycler®-Factor V Leiden MutationDetection Kit and the LightCycler®-Prothrombin Mutation Detection Kit

Nauck M., März W., Wieland H.

Clin Biochem 2000 Apr 1;33(3):213-216

LightCycler® technology for the quantitation of bcr/abl Fusion transcripts

Kreuzer K.-A., Lass U., Bohn A., Landt O., Schmidt C.A.

Cancer Res. (1999) 59: 3171-3174

Potential of LightCycler® technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia

Eckert C., Landt O., Taube T., Seeger K., Beyermann B., Proba .J, Henze G.

Leukemia 2000 Feb;14(2):316-23

Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler® technology

Nakao M., Janssen J.W.G., Seriu T., Bartram C.R.

Leukemia (2000) 14, 312-315

Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler® technology

Nakao M., Janssen J.W., Flohr T., Bartram C.R.

Cancer Res 2000 Jun 15;60(12):3281-9

Rapid real-time quantification of bcr-abl transcripts: intra- and inter-assay variation of a novel RT-PCR assay

Max N., Wolf K., Wittor B., Spike B., Burmeister T., Thiel E., Keilholz U.

Roche Molecular Biochemicals, Poster Reprint

Real-time quantification of bcr/abl mRNA transcripts using the LightCycler®-t (9;22) Quantification Kit

Wittor H., Leying H., Hochhaus A., Miltenburg R.v.

Biochemica, No.2, 2000